A novel HLA-B*57 allele, HLA-B*57:163, was identified by next generation sequencing typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
02 2023
Historique:
received: 27 09 2022
accepted: 29 09 2022
pubmed: 2 10 2022
medline: 21 1 2023
entrez: 1 10 2022
Statut: ppublish

Résumé

A novel allele HLA-B*57:163 was identified in a Russian male individual by next generation sequencing.

Identifiants

pubmed: 36181406
doi: 10.1111/tan.14838
doi:

Substances chimiques

HLA-B57 antigen 0
HLA Antigens 0
HLA-B Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-172

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P, Marsh SGE. IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Simakova T, Suvorova A, Krivonosova K, Abramova A, Loginova M, Paramonov I. NovAT tool-reliable novel HLA alleles identification from next generation sequencing data. HLA. 2022;99(1):3-11.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Maria Loginova (M)

Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.
Federal State Budget Educational Institution of Higher Professional Education, Vyatka State University, Kirov, Russia.

Daria Smirnova (D)

Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Igor Paramonov (I)

Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH